Pricing Log in Create free account

Affimed N.V. (AFMDQ) vs Ernexa Therapeutics Inc. (ERNA)

Affimed N.V. and Ernexa Therapeutics Inc. are both Biotechnology companies. Affimed N.V. and Ernexa Therapeutics Inc. are of similar size ($3.0M and $2.8M). Ernexa Therapeutics Inc. grew revenue faster over the last twelve months: −78.6% against −95.2%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (0.00% vs −13,558.8%). Across the 16 metrics below, Ernexa Therapeutics Inc. leads on 9 and Affimed N.V. on 7.

Valuation

Metric AFMDQ ERNA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.82 9.40
P/B n/m 0.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.26 n/m 0.66
EV/Sales (19.16) 50.76 9.02
Earnings yield 0.00% (992.55%) (32.88%)
Free cash flow yield 0.00% (399.18%) (23.13%)

Profitability

Metric AFMDQ ERNA Biotechnology median
Gross margin 100.00% 83.51% 68.51%
Operating margin (7,858.63%) 0.00% 0.00%
Net margin (7,834.59%) 0.00% 0.00%
Free cash flow margin (8,603.91%) 0.00% 0.00%
Return on equity (148.64%) (321.22%) (51.96%)
Return on assets (86.68%) (176.62%) (46.06%)
Return on invested capital (13,558.83%) 0.00% 0.00%

Growth

Metric AFMDQ ERNA Biotechnology median
Revenue growth (TTM) (95.23%) (78.60%) 6.76%
EPS growth (last fiscal year) (21.75%) 95.42% 29.88%
Revenue growth, 5-year CAGR (20.40%) (52.20%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ ERNA Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 2.01 4.97
Net debt to EBITDA 0.58 0.21 1.01

Dividend

Metric AFMDQ ERNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AFMDQ ERNA Biotechnology median
Market cap 2.76m 2.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack